Share

HIV drug suspended, withdrawn

The European Commission said on Tuesday it had suspended a license granted to Swiss drug-maker Roche to market the HIV drug Viracept in the European Union due to the toxic contamination of some tablets. The suspension followed the drug's withdrawal from the market in June.

The Swiss pharmaceutical group announced the major recall of the anti-HIV drug in June after discovering "the contamination of certain batches with ethyl mesilate, a genotoxic substance, which could cause tumors,” the Commission said in a statement.

The EU's decision is based on scientific conclusions of the European Medicines Agency (EMEA and follows consultation with member states.

"The suspension could only be lifted by a further decision by the Commission, after the evaluation of new data given by the Agency," the EU executive arm said. – Sapa

Read more:
The most effective HIV drugs
Anti-HIV drugs effective

We live in a world where facts and fiction get blurred
Who we choose to trust can have a profound impact on our lives. Join thousands of devoted South Africans who look to News24 to bring them news they can trust every day. As we celebrate 25 years, become a News24 subscriber as we strive to keep you informed, inspired and empowered.
Join News24 today
heading
description
username
Show Comments ()
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE